Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Top pharmaceutical companies manufacturing dymista?Cefpodoxime tablet name?Tepezza price in philippines?Trileptal generic name?Bisoprolol 2 5 mg price?
See the DrugPatentWatch profile for Spiriva
The query "Spiriva Respimat 4 grams" appears to be based on a misunderstanding of the medication's dosage. Spiriva Respimat is an inhaler used to treat chronic obstructive pulmonary disease (COPD). The active ingredient is tiotropium bromide, and it is typically delivered in microgram (mcg) doses, not grams.
Spiriva Respimat delivers 2.5 micrograms (mcg) of tiotropium per actuation. Patients are instructed to take two inhalations once daily [1]. This means a single daily dose provides 5 mcg of tiotropium.
Tiotropium bromide is a long-acting anticholinergic bronchodilator. It works by relaxing the muscles in the airways, making it easier to breathe [1].
Spiriva Respimat is a device that delivers a mist of medication. The tiotropium bromide in the mist blocks the action of acetylcholine on muscarinic receptors in the airways. This blockage leads to bronchodilation, which helps to relieve symptoms of COPD such as shortness of breath [1].
Drug patent information is complex and can vary by region and specific patent. Information on patent expiry dates for medications like Spiriva can often be found through specialized resources. For detailed insights into patent exclusivity and potential expiry dates related to Spiriva, DrugPatentWatch.com is a valuable resource [2].
Other Questions About Spiriva :